Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Status: | Recruiting |
---|---|
Conditions: | Infectious Disease, Gastrointestinal |
Therapuetic Areas: | Gastroenterology, Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 1 - Any |
Updated: | 2/10/2019 |
Start Date: | March 24, 1997 |
Contact: | Thomas W Brown, R.N. |
Email: | thomas.brown2@nih.gov |
Phone: | (301) 402-7823 |
Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection
The purpose of this study is to evaluate, treat and follow patients with parasitic
infections.
People with a known or suspected parasitic infection who are at least 1 year old may be
enrolled. This study does not involve any experimental treatments.
Participants will have a physical examination and laboratory tests on blood, stool, or urine.
Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of
blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds)
of body weight from children, in any 6-week period. Other tests may include x-rays,
electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample),
depending on the individual s condition.
Patients may be offered treatment or may be referred to another study that is more
appropriate for the problem. Any treatment provided in this study will be according to
standard medical practice for the patient s specific medical problem. Patients responses to
treatment will be evaluated at regularly scheduled clinic visits. The length of time between
visits and the total duration of the study for a given individual will be determined by the
study doctor, based on that person s medical condition.
infections.
People with a known or suspected parasitic infection who are at least 1 year old may be
enrolled. This study does not involve any experimental treatments.
Participants will have a physical examination and laboratory tests on blood, stool, or urine.
Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of
blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds)
of body weight from children, in any 6-week period. Other tests may include x-rays,
electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample),
depending on the individual s condition.
Patients may be offered treatment or may be referred to another study that is more
appropriate for the problem. Any treatment provided in this study will be according to
standard medical practice for the patient s specific medical problem. Patients responses to
treatment will be evaluated at regularly scheduled clinic visits. The length of time between
visits and the total duration of the study for a given individual will be determined by the
study doctor, based on that person s medical condition.
This study is designed as a prospective study to evaluate and treat patients with parasitic
infection. Patients with known or suspected parasitic infection will be enrolled and will be
evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit
will include a medical history, physical examination, routine laboratory tests and
specialized diagnostic procedures for possible parasitic infections. Treatment plans will be
individualized for each patient's particular condition, and the number and length of
additional visits and diagnostic evaluations will vary accordingly. Specific treatment
regimens will be in accordance with standard medical practice.
infection. Patients with known or suspected parasitic infection will be enrolled and will be
evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit
will include a medical history, physical examination, routine laboratory tests and
specialized diagnostic procedures for possible parasitic infections. Treatment plans will be
individualized for each patient's particular condition, and the number and length of
additional visits and diagnostic evaluations will vary accordingly. Specific treatment
regimens will be in accordance with standard medical practice.
- INCLUSION CRITERIA:
Age 1 or over.
Access to a primary medical care provider outside of the NIH.
Ability to give written informed consent (for adults) and parental consent (for those under
18).
Clinical evidence suggestive of a parasitic infection.
EXCLUSION CRITERIA:
Less than 1 year of age.
No evidence suggestive of a parasitic infection.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials